Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹11,340 |
| 2 | Schedule 2 | SUNIL PHARMACYLikely | RA Ended | 1 | ₹4,536 |
| 3 | Schedule 3 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹4,225.50 |
| 4 | Schedule 4 | VANDANA MEDICO TRADERSLikely | RA Ended | 1 | ₹2,952 |
| 5 | Schedule 5 | SUNIL PHARMACYLikely | RA Ended | 7 | ₹4,410 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 May 2024, 7:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Azathioprine 50mg Tab (Q3)
Betamethasone 0.1% w/w Cream (Q3)
Betaxolol (0.5% w/v) E/D bott of 5 ml (Q3)
Bimatoprost 0.03% w/v eye drops (Q3)
Chlordiazepoxide 5mg+ Clidinium Bromide 2.5 Mg (Librax) Tab (Q3)
Chloroquine Phosphate 250mg Tab (Q3)
Chlorphenaramine 50 mg Tab (Q3)
DESLORATADINE 5MG TAB (Q3)
Desmopressin 0.1mg Tab (Q3)
DESMOPRESSIN ACETATE NASAL SPRAY 1 MCG/ML BOTT OF 5 ML (Q3)
Desonide Cream (Q3)
DEVELOPER (Q3)
Dexamethasone 0.5mg Tab (Q3)
Diazepam 5mg Tab (Q3)
Diclofenac 50mg+ Paracetamol 325mg Tab (Q3)
FOSFOMYCIN SACHET 3GM (Q3)
FRUSEMIDE 10 Mg+ SPIRONOLACTONE 25 Mg TAB (Q3)
Frusemide 40 mg Tab (Q3)
6300535
GEM/2024/B/4850690
Two Packet Bid
Azathioprine 50mg Tab,Betamethasone 0.1% w/w Cream,Betaxolol (0.5% w/v) E/D bott of 5 ml,Bimatopros
30 days
Punjab; Amritsar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Azathioprine 50mg Tab (Q3) | AMRITSAR | 2,100 | 30 days | |
| Betamethasone 0.1% w/w Cream (Q3) | AMRITSAR | 360 | 30 days | |
| Betaxolol (0.5% w/v) E/D bott of 5 ml (Q3) | AMRITSAR | 90 | 30 days | |
| Bimatoprost 0.03% w/v eye drops (Q3) | AMRITSAR | 60 | 30 days | - |
| Chlordiazepoxide 5mg+ Clidinium Bromide 2.5 Mg (Librax) Tab (Q3) | AMRITSAR | 4,500 | 30 days | |
| Chloroquine Phosphate 250mg Tab (Q3) | AMRITSAR | 630 | 30 days | |
| Chlorphenaramine 50 mg Tab (Q3) | AMRITSAR | 300 | 30 days | |
| DESLORATADINE 5MG TAB (Q3) | AMRITSAR | 3,090 | 30 days | |
| Desmopressin 0.1mg Tab (Q3) | AMRITSAR | 570 | 30 days | |
| DESMOPRESSIN ACETATE NASAL SPRAY 1 MCG/ML BOTT OF 5 ML (Q3) | AMRITSAR | 150 | 30 days | |
| Desonide Cream (Q3) | AMRITSAR | 60 | 30 days | - |
| DEVELOPER (Q3) | AMRITSAR | 3 | 30 days | |
| Dexamethasone 0.5mg Tab (Q3) | AMRITSAR | 300 | 30 days | |
| Diazepam 5mg Tab (Q3) | AMRITSAR | 4,500 | 30 days | |
| Diclofenac 50mg+ Paracetamol 325mg Tab (Q3) | AMRITSAR | 39,000 | 30 days | |
| FOSFOMYCIN SACHET 3GM (Q3) | AMRITSAR | 300 | 30 days | |
| FRUSEMIDE 10 Mg+ SPIRONOLACTONE 25 Mg TAB (Q3) | AMRITSAR | 3,000 | 30 days | |
| Frusemide 40 mg Tab (Q3) | AMRITSAR | 4,560 | 30 days | - |
Exempted
16 May 2024
25 Apr 2024
16 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6300535.pdf
GEM_BID
re-07_2024-04-09-08-38-37_b6822bb340c462e4302e39a4cf67d044.pdf
SPECIFICATION
re-07_2024-04-09-08-39-02_830d5fc9e7f9f0e720db8c21bbd31a13.pdf
SPECIFICATION
re-07_2024-04-09-08-39-29_64aa8cadb1754cd9d8760da33cd1581f.pdf
SPECIFICATION
re-07_2024-04-09-08-39-57_be6bf654ceb1c2344444a3d8cf0df6f4.pdf
SPECIFICATION
re-07_2024-04-09-08-40-32_dfa3d731d0b1c37d20dd36b84b7f7dec.pdf
SPECIFICATION
re-07_2024-04-09-08-40-59_291dd783826ef3ea376ed7c17d70a3a5.pdf
SPECIFICATION
re-07_2024-04-09-08-41-30_26d2a9b3c6c84527e5c666f60b238fba.pdf
SPECIFICATION
re-07_2024-04-09-08-41-59_3f3d4f53022780a9261ab383bef77be1.pdf
SPECIFICATION
re-07_2024-04-09-08-43-03_92712a1979dfbabf08f0c6f0be2ceabc.pdf
SPECIFICATION
re-07_2024-04-09-08-44-10_ec9a534930e8e3cca0b59c98064877e9.pdf
SPECIFICATION
re-07_2024-04-09-08-44-36_7219ca57dabceeb26e2bced674c535a8.pdf
SPECIFICATION
re-07_2024-04-09-08-45-02_ec6ded7e4472f23a2ed4f562770ef0e9.pdf
SPECIFICATION
re-07_2024-04-09-08-45-28_3a42e26f74ecca6795b0e34f77eeede3.pdf
SPECIFICATION
re-07_2024-04-09-08-45-52_f79616b7751873e6689a9b1d5e50f8c5.pdf
SPECIFICATION
re-07_2024-04-09-08-46-15_af1ff2407216881f5fc6f62b3f042cb5.pdf
SPECIFICATION
re-07_2024-04-09-08-46-41_7132255949944d406a3d81e5c3bf45fd.pdf
SPECIFICATION
re-07_2024-04-09-08-47-07_c1b376f462e4fb5fb604d6a92f3f2de9.pdf
SPECIFICATION
re-07_2024-04-09-08-47-36_8b0555f792bda8105c344e9c77af7da8.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .